Novo Nordisk A/S B SHRS AdrhNVOHETF
13F holders, Q1 2025 (March 31)2holders
$40.04avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding Novo Nordisk A/S B SHRS Adrh (NVOH) in their 13F filings. The largest holders were GTS Securities LLC ($315K) and UBS Group AG ($13K).
- Company
- Novo Nordisk A/S B SHRS Adrh
- Filed as
- PRECIDIAN ETFS TR (Q1 2025)
- CUSIP
- 74016W841
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $328K |
| Exits | 0 | $0 |
Ownership 2 holders
| GTS Securities LLC | 0.01% | New | 7,858 | $315K |
| UBS Group AG | 0.00% | New | 335 | $13K |
"% of holder's portfolio" is NVOH's weight in each manager's 13F, not the share of Novo Nordisk A/S B SHRS Adrh the manager owns.